Technavio Publishes Global Osteoporosis Drugs Market Analysis 2015-2019

LONDON--()--Technavio has published a new industry analysis report on the global osteoporosis drugs market, which is expected to grow at a CAGR of more than 4% from 2015-2019.

About the Report

Osteoporosis is characterized by low bone density and structural deterioration of bone tissues, which leads to bone fragility and increased risk of fractures.

Due to rising life expectancies, the aging population has increased worldwide, leading to more osteoporosis cases.

“At the moment, osteoporotic fractures among the elderly in the US are the highest in the world,” says Faisal Ghaus, Vice President of Technavio.

“Though osteoporosis is more common in women than in men, the incidence in men is also continuously increasing.”

The latest market research conducted by Technavio also draws attention towards promotion of bone health awareness which helps reduce the rate and risk of osteoporosis.

“Increased awareness among patients and physicians will lead to early disease diagnosis and treatment, thus leading to better acceptability of osteoporosis drugs, increased drug penetration and steady market growth through the projected period,” says Ghaus.

Market Scope and Calculation of Market Size

The new Technavio report covers the present scenario and the growth prospects of the global osteoporosis drugs market from 2015-2019. To calculate the market size, the report considers revenue generated from sales of various osteoporosis drugs, which include both branded products and generics.

Key Information Covered in the Report:

  • Key Vendors:
    • Amgen Inc.
    • Eli Lilly & Co.
    • Merck & Co. Inc.
    • Novartis AG
  • Market Growth Drivers:
  • Market Challenges:
  • Market Trends:
    • Increase in Awareness of Bone Health Education
    • For a full detailed list, view our report.

Technavio currently has more than 3000 market research reports on a huge range of topics, including 200+ reports on the pharmaceuticals market:

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jes Ellacott
US: +1-630-333-9501
UK: +44 208 123 1770
Media & Marketing Executive
www.technavio.com
media@technavio.com

Release Summary

Technavio has published a new industry analysis report on the global osteoporosis drugs market, which is expected to grow at a CAGR of more than 4% from 2015-2019.

Contacts

Technavio Research
Jes Ellacott
US: +1-630-333-9501
UK: +44 208 123 1770
Media & Marketing Executive
www.technavio.com
media@technavio.com